Extra Super Avana contains two active ingredients: avanafil and dapoxetine. Avanafil is primarily metabolized by the liver, while dapoxetine is primarily metabolized by the liver and eliminated via the kidneys. Therefore, individuals with liver impairment may require dose adjustments or close monitoring when taking Extra Super Avana.

Liver function monitoring may be recommended by healthcare providers for individuals with pre-existing liver conditions, such as liver disease or impaired liver function. Monitoring liver function tests can help assess the impact of the medication on liver function and determine whether dose adjustments are necessary to ensure safe and effective treatment.

If you have any pre-existing liver conditions or concerns about liver function monitoring while taking Extra Super Avana, it's essential to discuss this with your healthcare provider. They can evaluate your individual situation and provide personalized recommendations for monitoring liver function and managing your treatment effectively while minimizing potential risks.